Woman in suit stands with arms folded in front of black background and VITALS logo

Transformational leader Crystal Mackall, M.D. (’84) joins VITALS on Thursday

Crystal Mackall, M.D. (’84), founding director of the Stanford Center for Cancer Cell Therapy, joins VITALS at noon Thursday, March 7, via Zoom.

VITALS | Visionary Health Leadership in Action is NEOMED’s monthly health leadership speaker series presented in collaboration with University Hospitals.

Dr. Mackall has led numerous first-in-human and first-in-child clinical trials spanning dendritic cell vaccines, cytokines and adoptive immunotherapy using NK cells and genetically modified T cells. Her work is credited with identifying an essential role for the thymus in human T cell regeneration (NEJM 1995) and discovering IL-7 as the master regulator of T cell homeostasis (Blood 2001, J Exp Med 2008).

She is the Ernest and Amelia Gallo Family Professor of Pediatrics and Medicine at Stanford University, associate director of the Stanford Cancer Institute, leader of the Cancer Immunotherapy Program and director of the Parker Institute for Cancer Immunotherapy at Stanford.

During a 27-year tenure at the National Cancer Institute, Dr. Mackall held multiple positions, culminating as chief of the Pediatric Oncology Branch and head of the Immunology Section. Since 2016 at Stanford, she has led an internationally recognized translational research program focused on immune-oncology. Her work has advanced understanding of fundamental immunology and translated this understanding for the treatment of human disease with a major focus on children’s cancers.

She has received numerous awards, including election to the National Academy of Medicine, American Society of Clinical Investigation and American Academy of Physicians, and she is a fellow of the AACR Academy. She received the Smalley Award for outstanding contributions to cancer immunotherapy from the Society for the Immunotherapy of Cancer, the AACR-St.Baldrick’s Distinguished Achievement Award for Pediatric Cancer Research, and the Nobility in Science Award from the Sarcoma Foundation of America. She has published over 250 manuscripts, her h-index in November 2022 according to Google Scholar is 96, she has founded three biotech companies, and holds multiple patents. Dr. Mackall is Board Certified in Pediatrics, Pediatric Hematology-Oncology and Internal Medicine.

Register for VITALS with Crystal Mackall, M.D.